Current commercial kinetic hydrate inhibitors (KHIs) are all based on water-soluble polymers with amphiphilic alkylamide or lactam groups. The size and shape of the hydrophobic moiety are known to be critical for optimum KHI performance. Proteins and peptides represent an environmentally friendly alternative, especially as bioengineering could be used to manufacture a product predetermined to have optimum KHI performance. Here, we explore a new series of polymers that are alternating dipeptoids where one of the peptide links originates from glycine. The dipeptoids contain
No takes yet. Share an insight, caveat, or question.
Kelland et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: